Company & Sponsor Intelligence
Wayne State University
Evidence-linked intelligence derived from the current NeuroRisk clinical research corpus. Coverage reflects indexed source data and is not a claim of complete company activity.
Request enterprise analysis →Indexed trials5
Recruiting1
Completed2
Countries1
Therapeutic footprint
epilepsyother_neurologyout_of_scopeparkinsonssubstance_use
Indexed studies
NCT03914599Protective Genetic Factors Against Neurological Diseases
other_neurology · United StatesCOMPLETED
other_neurology · United StatesCOMPLETED
NCT03858270Inhibition of α-synuclein Cell-cell Transmission by NMDAR Blocker, Memantine
parkinsons · United StatesPHASE3
parkinsons · United StatesPHASE3
NCT04986683Diffusion MRI Methods to Minimize Postoperative Deficits in Pediatric Epilepsy Surgery
epilepsy · United StatesNA
epilepsy · United StatesNA
NCT01959217Targeting PM to Improve HIV Adherence in Adolescents at Risk for Substance Abuse
substance_use · United StatesNA
substance_use · United StatesNA
NCT07793097Can Mindfulness and Virtual Reality Reduce Stress in Young Adults With Type 1 Diabetes?
out_of_scope · United StatesNA
out_of_scope · United StatesNA
Intelligence layer updated: 2026-10-11 23:31:09.606883+00:00
Enterprise intelligence
Compare sponsor activity, recruiting momentum, therapeutic exposure, geography and connected research signals across the neuroscience ecosystem.
Request comparative intelligence →